Previously recorded as Transunion Healthcare, Inc. (to 2024)
Three patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next US patent term in the Finthrive Healthcare, Inc. portfolio ends in Feb 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
3
Ending by 2030
Feb 2027
Next term end
2
Patent families
When these terms end
Each bar runs from grant to computed term end. 2010 to 2030.
US 7,797,165
Lossless Account Compression for Health Care Patient Benefits Eligibility Research System and Methods
no later than Feb 22, 2027
US 8,781,850
System and Method for Enhancing and Authenticating an Insurance Eligibility Transaction
Dec 11, 2030
20142018202220262030
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Dec 2030 · High confidence
Also notable
Ends Sep 2028 · High confidence
System and Method for Enhancing and Authenticating an Insurance Eligibility Transaction
US 8,781,850
The most cited patent in this portfolio, cited by 32 later US patents, top 25% of utility patents granted in 2014 in our data. Protection runs to 2030.
Health Care Patient Benefits Eligibility Research System and Methods
US 7,778,850
The largest patent family in this portfolio, 5 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Health Care Patient Benefits Eligibility Research System and Methods | 2 in force | to Sep 2028 |
| System and Method for Enhancing and Authenticating an Insurance Eligibility Transaction | 1 in force | to Dec 2030 |
Patents held now
Soonest term end first.
Showing 1 to 3 of 3
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,797,165 | Lossless Account Compression for Health Care Patient Benefits Eligibility Research System and Methods In force · Medium confidence | In force | Medium confidence | |
| US 7,778,850 | Health Care Patient Benefits Eligibility Research System and Methods In force · High confidence | In force | High confidence | |
| US 8,781,850 | System and Method for Enhancing and Authenticating an Insurance Eligibility Transaction In force · High confidence | In force | High confidence |
Also on record, not counted in the 3: 4 patents ended. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 terminal disclaimer is on file with no resolved reference. No cap is applied and none is guessed